Recent Data and Market Reaction: Can Gossamer Bio Deliver on Growth Hopes? If you have been eyeing Gossamer Bio (GOSS), this week’s developments might help you make a call. The company announced ...

Explore all key property features for 2 Gossamer Place, Macquarie Fields. Click here to find out more. What is the size of the property at 2 Gossamer Place, Macquarie Fields? The external land size ...

Overview: Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension in the United ...

The Dow Jones index closed higher by over 250 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders ...

- Primary endpoint of asthma worsening not met in LEDA Study, however consistent numeric reductions ranging from 32-35% observed across all three GB001 groups - - Statistically significant ...

Gossamer Bio has reappointed Faheem Hasnain as CEO one month after its lead drug failed in phase 2. Hasnain, the former CEO of Receptos, ran Gossamer Bio early in its history before handing off to ...

- Seralutinib demonstrated a placebo-adjusted improvement in Six-Minute Walk Distance (6MWD) of +13.3 meters at Week 24 (p = 0.0320), missing the prespecified alpha threshold of 0.025 - - At week 24, ...

Shares of Gossamer Bio Inc. plunged 64.5% in premarket trading on Tuesday after Wall Street analysts questioned the performance of the company's experimental hypertension drug in a Phase 2 clinical ...

The Dow Jones closed higher by around 490 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders ...

SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease ...